“No one should have to wait days—or weeks—for approval to receive needed care,” said Ganesh Padmanabhan, CEO of Autonomize AI ...

Vitamin D is another crucial component that boosts the immune system and prevents the development of insulin resistance. It ...

Originally launched at SITC 2024, the PhenoCode Discovery IO60 panel remains the fastest ultrahigh-plex spatial proteomics solution for immuno-oncology research. At AACR 2025, one of Akoya’s customers ...

A copy of the presentation materials can be accessed on the “ Publication ” section of the Company’s website at www.bioatla.com once the presentations have concluded.

Speakers for the events will include leading scientists from The Institute for Protein Innovation (IPI), Pfizer, GSK, ACROBiosystems, Bio-Techne, Curia, ImmunoPrecise Antibodies (IPA), Ordaos, The ...

PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin ...

New drug testing kits help festival goers detect dangerous substances, promoting safer choices and harm reduction. Test Your ...

Cocrystal Pharma’s pan-viral protease inhibitor CDI-988 shows superior broad-spectrum antiviral activity against major norovirus variants including GII.4 and GII.17 strains ...

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox. TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa ...

The Enable Atlas’s spatial proteomics layer was generated using Akoya’s PhenoCycler-Fusion, the industry’s fastest and most scalable spatial biology platform, and included the ultrahigh-plex IO60 ...

BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of ...

NDV-01 is a novel, investigational, sustained-release gemcitabine/docetaxel formulation, designed as a ready-for-use intravesical therapy for the treatment of NMIBC. The U.S. prevalence of NMIBC is ...